First Light Asset Management, LLC — 13F Holdings & Portfolio
CIK 1600004 · latest 13F-HR filed 2026-05-15
First Light Asset Management, LLC manages $1.12B in 13F-reported U.S. long-equity assets across 35 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are AXGN (11.88%), PVLA (10.96%), NEO (6.47%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 7 new positions, exited 5, added to 8, and trimmed 17.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$1.12B
Long-equity book
35
Distinct positions
2026-03-31
Filed 2026-05-15
+7 / −5 / ↑8 / ↓17
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- PALVELLA THERAPEUTICS INC$48.0M +64.7%
- APOGEE THERAPEUTICS INC$27.0M +125.6%
- 908 DEVICES INC$11.8M +46.4%
- NEUROPACE INC$11.5M +55.3%
- TWIST BIOSCIENCE CORPORATION$5.6M +15.4%
Top Trims
- NEOGENOMICS INC-$45.8M -38.8%
- AXOGEN INC-$38.7M -22.6%
- SI-BONE INC-$31.6M -31.9%
- VERA THERAPEUTICS INC-$31.4M -71.3%
- ATRICURE INC-$25.7M -55.2%
New Positions
- TRISALUS LIFE SCIENCES INC$20.3M
- TECTONIC THERAPEUTICS INC$20.0M
- OMNICELL INC$16.4M
- GENEDX HOLDINGS CORP$15.6M
- SPYGLASS PHARMA INC$9.7M
Exited Positions
- DISC MEDICINE INC$41.5M
- MADRIGAL PHARMACEUTICALS INC$38.9M
- ABIVAX SA-ADR$12.0M
- DYNE THERAPEUTICS INC$3.0M
- ISHARES RUSSELL 2000 GROWTH ETF$245.5K
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | AXOGEN INC | AXGN | 05463X106 | $132.6M | 11.88% | 4,002,768 | SH |
| 2 | PALVELLA THERAPEUTICS INC | PVLA | 697947109 | $122.3M | 10.96% | 980,758 | SH |
| 3 | NEOGENOMICS INC | NEO | 64049M209 | $72.2M | 6.47% | 9,729,978 | SH |
| 4 | SI-BONE INC | SIBN | 825704109 | $67.6M | 6.06% | 5,353,190 | SH |
| 5 | CENTESSA PHARMACEUTICALS LIMITED | CNTA | 152309100 | $62.0M | 5.56% | 1,560,991 | SH |
| 6 | APOGEE THERAPEUTICS INC | APGE | 03770N101 | $48.5M | 4.35% | 576,684 | SH |
| 7 | AMYLYX PHARMACEUTICALS INC | AMLX | 03237H101 | $44.3M | 3.97% | 3,190,645 | SH |
| 8 | TWIST BIOSCIENCE CORPORATION | TWST | 90184D100 | $41.8M | 3.74% | 878,848 | SH |
| 9 | CRINETICS PHARMACEUTICALS INC | CRNX | 22663K107 | $39.6M | 3.55% | 1,089,670 | SH |
| 10 | 908 DEVICES INC | MASS | 65443P102 | $37.2M | 3.33% | 6,072,563 | SH |
| 11 | NEUROPACE INC | NPCE | 641288105 | $32.3M | 2.90% | 2,459,966 | SH |
| 12 | EDGEWISE THERAPEUTICS INC | EWTX | 28036F105 | $31.6M | 2.83% | 1,001,846 | SH |
| 13 | ANAPTYS BIO INC | ANAB | 032724106 | $31.4M | 2.81% | 565,431 | SH |
| 14 | SIMULATIONS PLUS INC | SLP | 829214105 | $31.1M | 2.79% | 2,632,823 | SH |
| 15 | GUARDANT HEALTH | GH | 40131M109 | $25.9M | 2.32% | 280,299 | SH |
| 16 | TANDEM DIABETES CARE INC | TNDM | 875372203 | $25.2M | 2.26% | 1,314,715 | SH |
| 17 | ATRICURE INC | ATRC | 04963C209 | $20.8M | 1.87% | 729,521 | SH |
| 18 | TRISALUS LIFE SCIENCES INC | TLSI | 89680M101 | $20.3M | 1.82% | 5,066,827 | SH |
| 19 | TECTONIC THERAPEUTICS INC | TECX | 878972108 | $20.0M | 1.79% | 647,743 | SH |
| 20 | IRHYTHM TECHNOLOGIES | IRTC | 450056106 | $19.8M | 1.78% | 168,116 | SH |
| 21 | SEPTERNA INC | SEPN | 81734D104 | $17.6M | 1.58% | 732,860 | SH |
| 22 | ESTABLISHMENT LABS HOLDINGS | ESTA | G31249108 | $17.5M | 1.57% | 307,738 | SH |
| 23 | HEALTH CATALYST INC | HCAT | 42225T107 | $16.4M | 1.47% | 12,878,700 | SH |
| 24 | OMNICELL INC | OMCL | 68213N109 | $16.4M | 1.47% | 489,846 | SH |
| 25 | KORU MEDICAL SYSTEMS INC | KRMD | 759910102 | $16.3M | 1.46% | 3,768,380 | SH |
| 26 | GENEDX HOLDINGS CORP | WGS | 81663L200 | $15.6M | 1.40% | 242,927 | SH |
| 27 | WAVE LIFE SCIENCES LTD | WVE | Y95308105 | $13.4M | 1.20% | 1,843,968 | SH |
| 28 | VERA THERAPEUTICS INC | VERA | 92337R101 | $12.6M | 1.13% | 313,906 | SH |
| 29 | MIMEDX GROUP INC | MDXG | 602496101 | $11.2M | 1.01% | 2,842,892 | SH |
| 30 | BUTTERFLY NETWORK INC | BFLY | 124155102 | $10.7M | 0.96% | 2,660,167 | SH |
| 31 | SPYGLASS PHARMA INC | SGP | 85220G109 | $9.7M | 0.87% | 375,000 | SH |
| 32 | ORGANOGENESIS HOLDINGS INC | ORGO | 68621F102 | $8.3M | 0.74% | 3,498,533 | SH |
| 33 | VAXCYTE INC | PCVX | 92243G108 | $8.2M | 0.74% | 141,784 | SH |
| 34 | ENLIVEN THERAPEUTICS INC | ELVN | 29337E102 | $7.9M | 0.71% | 201,867 | SH |
| 35 | RHYTHM PHARMACEUTICALS INC | RYTM | 76243J105 | $7.6M | 0.68% | 87,181 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-15 | $1.12B | 35 | 0001999371-26-010896 |
| 2025-12-31 | 2026-02-17 | $1.31B | 33 | 0001999371-26-003511 |
| 2025-09-30 | 2025-11-14 | $1.06B | 41 | 0001999371-25-017920 |